300702.SZ · 天宇股份
China A-shares · RS rating 81 · As of 2026-10-14
| Price | 21.77 CNY |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 81 / 83 / 69 / 47 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 41 / 34 / 25 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +47.7% |
| Distance from 52-week high | +20.5% |
| Market cap (USD) | $1.2B |